Aarti Drugs Ltd reports consolidated PAT of Rs. 42.59 crore in Q2 FY2021-22

Aarti Drugs Limited has reported Consolidated financial results for the period ended September 30, 2021.

Financial Results (Q1 FY2022) - QoQ Comparison

The company has reported total income of Rs. 579.70 crores during the period ended September 30, 2021 as compared to Rs. 581.57 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs. 42.59 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 48.81 crores for the period ended March 31, 2021.

The company has reported EPS of Rs. 4.60 for the period ended September 30, 2021 as compared to Rs. 5.25 for the period ended March 31, 2021.

Financials	Q1 FY2022	Q4 FY2021	% Change
Total Income	₹ 579.70 crs	₹581.57 crs	-0.32%
Net Profit	₹42.59 crs	₹48.81 crs	-12.74%
EPS	₹4.60	₹5.25	-12.38%

Financial Results (Q1 FY2022) - YoY Comparison

The company has reported total income of Rs. 579.70 crores during the period ended September 30, 2021 as compared to Rs.578.40 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.42.59 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.75.27 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.4.60 for the period ended September 30, 2021 as compared to Rs.8.08 for the period ended September 30, 2020.

Financials	Q1 FY2022	Q1 FY2021	% Change
Total Income	₹ 579.70 crs	₹578.40 crs	0.22%
Net Profit	₹42.59 crs	₹75.27 crs	-43.42%
EPS	₹4.60	₹8.08	-43.07%

Shares of Aarti Drugs Limited was last trading in BSE at Rs. 622.30 as compared to the previous close of Rs. 631.90. The total number of shares traded during the day was 6825 in over 759 trades.

The stock hit an intraday high of Rs. 641.00 and intraday low of 619.20. The net turnover during the day was Rs. 4272438.00.

Source : Equity Bulls

Keywords

AartiDrugs Q2FY22 H1FY22 ResultUpdate